1	Hombre	hombre	NCMS000	C0025266#C0086418#C0043210	persona#organismo_vivo	0-6	295_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	7-9	295_QUEST_clinical_caseMIR	SENT1	-	-
3	49	49		-	-	10-12	295_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	13-17	295_QUEST_clinical_caseMIR	SENT1	-	-
5	que	que	PR0CN000	-	-	18-21	295_QUEST_clinical_caseMIR	SENT1	-	-
6	consulta	consultar	VMM02S0	C1704447_1	calificador_1	22-30	295_QUEST_clinical_caseMIR	SENT1	-	-
7	por	por	SPS00	C1704447_2	calificador_2	31-34	295_QUEST_clinical_caseMIR	SENT1	-	-
8	poliuria	poliuria	NCFS000	C0032617	hallazgo#trastorno	35-43	295_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
9	y	y	CC	C1706368	calificador	44-45	295_QUEST_clinical_caseMIR	SENT1	-	-
10	polidipsia	polidipsia	NCFS000	C1994994#C0085602	hallazgo	46-56	295_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
11	intensas	intenso	AQ0FP0	C0205178	calificador	57-65	295_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
12	y	y	CC	C1706368	calificador	66-67	295_QUEST_clinical_caseMIR	SENT1	-	-
13	pérdida	pérdida	NCFS000	-	-	68-75	295_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
14	involuntaria	involuntario	AQ0FS0	-	-	76-88	295_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
15	de	de	SPS00	C0332285	atributo	89-91	295_QUEST_clinical_caseMIR	SENT1	-	-
16	10	10	Z	-	-	92-94	295_QUEST_clinical_caseMIR	SENT1	-	-
17	kg	kg	NCMN000	-	-	95-97	295_QUEST_clinical_caseMIR	SENT1	-	-
18	de	de	SPS00	C0332285	atributo	98-100	295_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
19	peso	peso	NCMS000	C0043100	calificador	101-105	295_QUEST_clinical_caseMIR	SENT1	I-Calificador	-
20	y	y	CC	C1706368	calificador	106-107	295_QUEST_clinical_caseMIR	SENT1	-	-
21	es	ser	VSIP3S0	-	-	108-110	295_QUEST_clinical_caseMIR	SENT1	-	-
22	diagnosticado	diagnosticar	VMP00SM	-	-	111-124	295_QUEST_clinical_caseMIR	SENT1	-	-
23	de	de	SPS00	C0332285	atributo	125-127	295_QUEST_clinical_caseMIR	SENT1	-	-
24	diabetes	diabetes	NCFN000	C0011849_1	trastorno_1	128-136	295_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
25	mellitus	mellitus	AQ0CN0	C0011849_2	trastorno_2	137-145	295_QUEST_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-
26	por	por	SPS00	C0678226	atributo	146-149	295_QUEST_clinical_caseMIR	SENT1	-	-
27	una	una		C0205447_1	calificador_1	150-153	295_QUEST_clinical_caseMIR	SENT1	-	-
28	glucemia	glucemia	NCFS000	C2585282	entidad_observable	154-162	295_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
29	plasmática	plasmático	AQ0FS0	-	-	163-173	295_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
30	de	de	SPS00	C0332285	atributo	174-176	295_QUEST_clinical_caseMIR	SENT1	-	-
31	322	322	Z	-	-	177-180	295_QUEST_clinical_caseMIR	SENT1	-	-
32	mg	mg	NCMN000	-	-	181-183	295_QUEST_clinical_caseMIR	SENT1	-	-
33	/	/	Fh	-	-	183-184	295_QUEST_clinical_caseMIR	SENT1	-	-
34	dL	decilitro	NCMN000	C0439241	calificador	184-186	295_QUEST_clinical_caseMIR	SENT1	-	-
35	y	y	CC	C1706368	calificador	187-188	295_QUEST_clinical_caseMIR	SENT1	-	-
36	una	una		C0205447_1	calificador_1	189-192	295_QUEST_clinical_caseMIR	SENT1	-	-
37	hemoglobina	hemoglobina	NCFS000	C0019046	sustancia	193-204	295_QUEST_clinical_caseMIR	SENT1	-	-
38	glicosilada	glicosilada	VMP00SF	-	-	205-216	295_QUEST_clinical_caseMIR	SENT1	-	-
39	de	de	SPS00	C0332285	atributo	217-219	295_QUEST_clinical_caseMIR	SENT1	-	-
40	9,8	9.8	Z	-	-	220-223	295_QUEST_clinical_caseMIR	SENT1	-	-
41	%	%	Ft	-	-	223-224	295_QUEST_clinical_caseMIR	SENT1	-	-
42	.	.	Fp	-	-	224-225	295_QUEST_clinical_caseMIR	SENT1	-	-

1	Su	su	DP3CS0	-	-	226-228	295_QUEST_clinical_caseMIR	SENT2	-	-
2	médico	médico	AQ0MS0	C0205476#C0031831	calificador#ocupación	229-235	295_QUEST_clinical_caseMIR	SENT2	-	-
3	le	le	NC00SC0	C1292157#C0409974	hallazgo#trastorno	236-238	295_QUEST_clinical_caseMIR	SENT2	-	-
4	da	da	NC00YL0	C0226032	estructura_corporal	239-241	295_QUEST_clinical_caseMIR	SENT2	-	-
5	recomendaciones	recomendación	NCFP000	C0150600	procedimiento	242-257	295_QUEST_clinical_caseMIR	SENT2	-	-
6	dietéticas	dietético	AQ0FP0	-	-	258-268	295_QUEST_clinical_caseMIR	SENT2	-	-
7	,	,	Fc	-	-	268-269	295_QUEST_clinical_caseMIR	SENT2	-	-
8	la	el	DA0FS0	-	-	270-272	295_QUEST_clinical_caseMIR	SENT2	-	-
9	conveniencia	conveniencia	NCFS000	-	-	273-285	295_QUEST_clinical_caseMIR	SENT2	-	-
10	de	de	SPS00	C0332285	atributo	286-288	295_QUEST_clinical_caseMIR	SENT2	-	-
11	realizar	realizar	VMN0000	-	-	289-297	295_QUEST_clinical_caseMIR	SENT2	-	-
12	ejercicio	ejercicio	NCMS000	C0015259_1	calificador_1	298-307	295_QUEST_clinical_caseMIR	SENT2	-	-
13	físico	físico	NCMS000	C0015259_2	calificador_2	308-314	295_QUEST_clinical_caseMIR	SENT2	-	-
14	,	,	Fc	-	-	314-315	295_QUEST_clinical_caseMIR	SENT2	-	-
15	e	y	CC	C1706368	calificador	316-317	295_QUEST_clinical_caseMIR	SENT2	-	-
16	inicia	iniciar	VMIP3S0	-	-	318-324	295_QUEST_clinical_caseMIR	SENT2	-	-
17	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	325-336	295_QUEST_clinical_caseMIR	SENT2	-	-
18	con	con	SPS00	C0332287	atributo	337-340	295_QUEST_clinical_caseMIR	SENT2	-	-
19	metformina	metformina	NC00SC0	C0025598	producto#sustancia	341-351	295_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
20	850	850		-	-	352-355	295_QUEST_clinical_caseMIR	SENT2	-	-
21	mg/12	mg/12	Z	-	-	356-361	295_QUEST_clinical_caseMIR	SENT2	-	-
22	horas	h	NCFP000	C0439227	calificador	362-367	295_QUEST_clinical_caseMIR	SENT2	-	-
23	y	y	CC	C1706368	calificador	368-369	295_QUEST_clinical_caseMIR	SENT2	-	-
24	glimepirida	glimepirida	NC00SC0	C0061323	producto#sustancia	370-381	295_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
25	6	6	Z	-	-	382-383	295_QUEST_clinical_caseMIR	SENT2	-	-
26	mg	mg	NCMN000	-	-	384-386	295_QUEST_clinical_caseMIR	SENT2	-	-
27	/	/	Fh	-	-	386-387	295_QUEST_clinical_caseMIR	SENT2	-	-
28	dia	dia	NC00YL0	-	-	387-390	295_QUEST_clinical_caseMIR	SENT2	-	-
29	.	.	Fp	-	-	390-391	295_QUEST_clinical_caseMIR	SENT2	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	392-394	295_QUEST_clinical_caseMIR	SENT3	-	-
2	las	el	DA0FP0	-	-	395-398	295_QUEST_clinical_caseMIR	SENT3	-	-
3	semanas	semana	NCFP000	C0439230	calificador	399-406	295_QUEST_clinical_caseMIR	SENT3	-	-
4	siguientes	siguiente	AQ0CP0	C0332282	atributo	407-417	295_QUEST_clinical_caseMIR	SENT3	-	-
5	los	el	DA0MP0	-	-	418-421	295_QUEST_clinical_caseMIR	SENT3	-	-
6	controles	control	NCMP000	C2587213	atributo	422-431	295_QUEST_clinical_caseMIR	SENT3	-	-
7	glucémicos	glucémico	AQ0MP0	-	-	432-442	295_QUEST_clinical_caseMIR	SENT3	-	-
8	se	se	P00CN000	-	-	443-445	295_QUEST_clinical_caseMIR	SENT3	-	-
9	van	ir	VMIP3P0	-	-	446-449	295_QUEST_clinical_caseMIR	SENT3	-	-
10	reduciendo	reducir	VMG0000	-	-	450-460	295_QUEST_clinical_caseMIR	SENT3	-	-
11	progresivamente	progresivamente	RG	-	-	461-476	295_QUEST_clinical_caseMIR	SENT3	-	-
12	.	.	Fp	-	-	476-477	295_QUEST_clinical_caseMIR	SENT3	-	-

1	A	a	SPS00	-	-	478-479	295_QUEST_clinical_caseMIR	SENT4	-	-
2	los	el	DA0MP0	-	-	480-483	295_QUEST_clinical_caseMIR	SENT4	-	-
3	4	4		-	-	484-485	295_QUEST_clinical_caseMIR	SENT4	-	-
4	meses	mes	NCMP000	C0439231	calificador	486-491	295_QUEST_clinical_caseMIR	SENT4	-	-
5	la	el	DA0FS0	-	-	492-494	295_QUEST_clinical_caseMIR	SENT4	-	-
6	glucemia	glucemia	NCFS000	C2585282	entidad_observable	495-503	295_QUEST_clinical_caseMIR	SENT4	-	-
7	es	ser	VSIP3S0	-	-	504-506	295_QUEST_clinical_caseMIR	SENT4	-	-
8	de	de	SPS00	C0332285	atributo	507-509	295_QUEST_clinical_caseMIR	SENT4	-	-
9	94	94	Z	-	-	510-512	295_QUEST_clinical_caseMIR	SENT4	-	-
10	mg	mg	NCMN000	-	-	513-515	295_QUEST_clinical_caseMIR	SENT4	-	-
11	/	/	Fh	-	-	515-516	295_QUEST_clinical_caseMIR	SENT4	-	-
12	dL	decilitro	NCMN000	C0439241	calificador	516-518	295_QUEST_clinical_caseMIR	SENT4	-	-
13	y	y	CC	C1706368	calificador	519-520	295_QUEST_clinical_caseMIR	SENT4	-	-
14	la	el	DA0FS0	-	-	521-523	295_QUEST_clinical_caseMIR	SENT4	-	-
15	HbA1c	HbA1c		-	-	524-529	295_QUEST_clinical_caseMIR	SENT4	-	-
16	de	de	SPS00	C0332285	atributo	530-532	295_QUEST_clinical_caseMIR	SENT4	-	-
17	5,9	5.9	Z	-	-	533-536	295_QUEST_clinical_caseMIR	SENT4	-	-
18	%	%	Ft	-	-	536-537	295_QUEST_clinical_caseMIR	SENT4	-	-
19	.	.	Fp	-	-	537-538	295_QUEST_clinical_caseMIR	SENT4	-	-

1	El	el	DA0MS0	-	-	539-541	295_QUEST_clinical_caseMIR	SENT5	-	-
2	paciente	paciente	NCCS000	C0030705	persona	542-550	295_QUEST_clinical_caseMIR	SENT5	-	-
3	se	se	P00CN000	-	-	551-553	295_QUEST_clinical_caseMIR	SENT5	-	-
4	queja	quejar	VMIP3S0	-	-	554-559	295_QUEST_clinical_caseMIR	SENT5	-	-
5	de	de	SPS00	C0332285	atributo	560-562	295_QUEST_clinical_caseMIR	SENT5	-	-
6	episodios	episodio	NCMP000	C0332189	atributo	563-572	295_QUEST_clinical_caseMIR	SENT5	-	-
7	frecuentes	frecuente	AQ0CP0	C0332183	calificador	573-583	295_QUEST_clinical_caseMIR	SENT5	-	-
8	de	de	SPS00	C0332285	atributo	584-586	295_QUEST_clinical_caseMIR	SENT5	-	-
9	mareo	mareo	NCMS000	C0012833#C0220870	hallazgo	587-592	295_QUEST_clinical_caseMIR	SENT5	B-Grp_Enfermedad	-
10	,	,	Fc	-	-	592-593	295_QUEST_clinical_caseMIR	SENT5	-	-
11	dolor	dolor	NCMS000	C0232493_1	hallazgo_1	594-599	295_QUEST_clinical_caseMIR	SENT5	B-Grp_Enfermedad	-
12	epigástrico	epigástrico	AQ0MS0	C0232493_2	hallazgo_2	600-611	295_QUEST_clinical_caseMIR	SENT5	B-Estructura_Corporal	-
13	,	,	Fc	-	-	611-612	295_QUEST_clinical_caseMIR	SENT5	-	-
14	visión	visión	NCFS000	C0344232_1	hallazgo#trastorno_1	613-619	295_QUEST_clinical_caseMIR	SENT5	B-Grp_Enfermedad	-
15	borrosa	borroso	AQ0FS0	C0344232_2	hallazgo#trastorno_2	620-627	295_QUEST_clinical_caseMIR	SENT5	I-Grp_Enfermedad	-
16	,	,	Fc	-	-	627-628	295_QUEST_clinical_caseMIR	SENT5	-	-
17	sudoración	sudoración	NCFS000	C0038990_1	entidad_observable#hallazgo_1	629-639	295_QUEST_clinical_caseMIR	SENT5	B-Grp_Enfermedad	-
18	y	y	CC	C1706368	calificador	640-641	295_QUEST_clinical_caseMIR	SENT5	-	-
19	temblor	temblor	NCMS000	C0040822#C1527384_1	hallazgo_1	642-649	295_QUEST_clinical_caseMIR	SENT5	B-Grp_Enfermedad	-
20	,	,	Fc	-	-	649-650	295_QUEST_clinical_caseMIR	SENT5	-	-
21	que	que	PR0CN000	-	-	651-654	295_QUEST_clinical_caseMIR	SENT5	-	-
22	mejoran	mejorar	VMIP3P0	-	-	655-662	295_QUEST_clinical_caseMIR	SENT5	-	-
23	comiendo	comer	VMG0000	C0013470	función	663-671	295_QUEST_clinical_caseMIR	SENT5	-	-
24	algo	algo	PI0CS000	-	-	672-676	295_QUEST_clinical_caseMIR	SENT5	-	-
25	y	y	CC	C1706368	calificador	677-678	295_QUEST_clinical_caseMIR	SENT5	-	-
26	que	que	PR0CN000	-	-	679-682	295_QUEST_clinical_caseMIR	SENT5	-	-
27	ocurren	ocurrir	VMIP3P0	-	-	683-690	295_QUEST_clinical_caseMIR	SENT5	-	-
28	sobre	sobre	SPS00	C1720294#C0205136	calificador	691-696	295_QUEST_clinical_caseMIR	SENT5	-	-
29	todo	todo	PI0MS000	C0205197#C0439810#C0444868#C0444667	calificador	697-701	295_QUEST_clinical_caseMIR	SENT5	-	-
30	al	al	SP+DA	-	-	702-704	295_QUEST_clinical_caseMIR	SENT5	-	-
31	final	final	NCMS000	C0444930	calificador	705-710	295_QUEST_clinical_caseMIR	SENT5	-	-
32	de	de	SPS00	C0332285	atributo	711-713	295_QUEST_clinical_caseMIR	SENT5	-	-
33	la	el	DA0FS0	-	-	714-716	295_QUEST_clinical_caseMIR	SENT5	-	-
34	mañana	mañana	NCMS000	C0332170	calificador	717-723	295_QUEST_clinical_caseMIR	SENT5	-	-
35	y	y	CC	C1706368	calificador	724-725	295_QUEST_clinical_caseMIR	SENT5	-	-
36	al	al	SP+DA	-	-	726-728	295_QUEST_clinical_caseMIR	SENT5	-	-
37	final	final	NCMS000	C0444930	calificador	729-734	295_QUEST_clinical_caseMIR	SENT5	-	-
38	de	de	SPS00	C0332285	atributo	735-737	295_QUEST_clinical_caseMIR	SENT5	-	-
39	la	el	DA0FS0	-	-	738-740	295_QUEST_clinical_caseMIR	SENT5	-	-
40	tarde	tarde	NCFS000	C0205087#C0439550	calificador	741-746	295_QUEST_clinical_caseMIR	SENT5	-	-
41	.	.	Fp	-	-	746-747	295_QUEST_clinical_caseMIR	SENT5	-	-

1	¿	¿	Fia	-	-	748-749	295_QUEST_clinical_caseMIR	SENT6	-	-
2	Qué	qué	DT0CN0	-	-	749-752	295_QUEST_clinical_caseMIR	SENT6	-	-
3	modificación	modificación	NCFS000	-	-	753-765	295_QUEST_clinical_caseMIR	SENT6	-	-
4	propondria	propondria	NCFS000	-	-	766-776	295_QUEST_clinical_caseMIR	SENT6	-	-
5	en	en	SPS00	C1720294#C0332285	calificador#atributo	777-779	295_QUEST_clinical_caseMIR	SENT6	-	-
6	su	su	DP3CS0	-	-	780-782	295_QUEST_clinical_caseMIR	SENT6	-	-
7	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	783-794	295_QUEST_clinical_caseMIR	SENT6	-	-
8	?	?	Fit	-	-	794-795	295_QUEST_clinical_caseMIR	SENT6	-	-
9	.	.	Fp	-	-	795-796	295_QUEST_clinical_caseMIR	SENT6	-	-

